Abstract.
The effects of an imidazoline compound (BL11282) on protein expression in rat pancreatic islets were investigated with a proteomic approach. The compound increases insulin release selectively at high glucose concentrations and is therefore of interest in type 2 diabetes. Whole cell extracts from isolated drug-treated and native pancreatic rat islets were compared after separation by 2-D gel electrophoresis. Differentially expressed proteins were identified by mass spectrometry; 15 proteins were selectively up-regulated and 7 selectively down-regulated in drug-treated islets. Of special interest among the differentially expressed proteins are those involved in protein folding (Hsp60, protein disulfide isomerase, calreticulin), Ca2+ binding (calgizzarin, calcyclin and annexin I) and metabolism or signalling (pyruvate kinase, alpha enolase and protein kinase C inhibitor 1).
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 19 March 2007; received after revision 11 April 2007; accepted 11 April 2007
Rights and permissions
About this article
Cite this article
Jägerbrink, T., Lexander, H., Palmberg, C. et al. Differential protein expression in pancreatic islets after treatment with an imidazoline compound. Cell. Mol. Life Sci. 64, 1310 (2007). https://doi.org/10.1007/s00018-007-7136-5
Published:
DOI: https://doi.org/10.1007/s00018-007-7136-5